--- title: Simsen Diagnostics to Present at GoCo Investor Day, Autumn 2025 description: Simsen Diagnostics is excited to announce our participation in the upcoming GoCo Investor Day image: https://simsendiagnostics.com/hubfs/News-background.png --- [Skip to the main content.](https://simsendiagnostics.com/news/goco-investor-day-autumn-2025#main-content) [![Simsen logotype](https://simsendiagnostics.com/hs-fs/hubfs/SD_logo%20medium-2.png?width=588&height=164&name=SD_logo%20medium-2.png "Simsen logotype")](https://simsendiagnostics.com) [![Simsen logotype](https://simsendiagnostics.com/hs-fs/hubfs/SD_logo%20medium-2.png?width=588&height=164&name=SD_logo%20medium-2.png "Simsen logotype")](https://simsendiagnostics.com) - [PLATFORM](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Methodology](https://simsendiagnostics.com/platform-methodology) - [Find your approach](https://simsendiagnostics.com/find-your-approach) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) - [Solutions](https://simsendiagnostics.com/solutions-overview) - [EVIDENCE](https://simsendiagnostics.com/evidence-hub) - [Publications](https://simsendiagnostics.com/evidence-publications) - [Paediatric solid tumours](https://simsendiagnostics.com/evidence-paediatric-solid-tumours) - [CNS tumours & CSF ctDNA](https://simsendiagnostics.com/evidence-cns-csf-ctdna) - [White papers](https://simsendiagnostics.com/evidence-white-paper-ctdna-trials) - [COMPANY](https://simsendiagnostics.com/company-about) - [About us](https://simsendiagnostics.com/company-about) - [Team](https://simsendiagnostics.com/company-team) - [Contact us](https://simsendiagnostics.com/company-contact) - [News](https://simsendiagnostics.com/news) - [RESOURCES](https://simsendiagnostics.com/resources-hub) - [Sample collection guides](https://simsendiagnostics.com/resources-sample-collection-guides) - [Baseline kit guide](https://simsendiagnostics.com/baseline-collection-kit) - [Follow-up kit guide](https://simsendiagnostics.com/resources-followup-collection-kit) Search [![Request a conversation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/25734893/interactive-412216133822.png)](https://simsendiagnostics.com/hs/cta/wi/redirect?encryptedPayload=AVxigLKH%2Fq9%2FsD8Fo8YI%2BECIgZuLoxZR0g57lLX7SyWbYMdFpEYGUGf8FEF3M46bfpVLlW2qMUbwdn4wZpcvANa7b0seqLsovde9sByV2SFf18QID%2FIHeBE2X2WwGEyfg%2BTK86UFKAHiYlrU4Nvy%2BYNIhU9JmvcacgArbliATD7le28kjYjhlMl2ELwH5zNYMWjc0CMLVyUU&webInteractiveContentId=412216133822&portalId=25734893) Toggle Menu Search Toggle Menu [![Request a conversation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/25734893/interactive-412216133822.png)](https://simsendiagnostics.com/hs/cta/wi/redirect?encryptedPayload=AVxigLKH%2Fq9%2FsD8Fo8YI%2BECIgZuLoxZR0g57lLX7SyWbYMdFpEYGUGf8FEF3M46bfpVLlW2qMUbwdn4wZpcvANa7b0seqLsovde9sByV2SFf18QID%2FIHeBE2X2WwGEyfg%2BTK86UFKAHiYlrU4Nvy%2BYNIhU9JmvcacgArbliATD7le28kjYjhlMl2ELwH5zNYMWjc0CMLVyUU&webInteractiveContentId=412216133822&portalId=25734893) - [PLATFORM](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Methodology](https://simsendiagnostics.com/platform-methodology) - [Find your approach](https://simsendiagnostics.com/find-your-approach) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) - [Solutions](https://simsendiagnostics.com/solutions-overview) - [EVIDENCE](https://simsendiagnostics.com/evidence-hub) - [Publications](https://simsendiagnostics.com/evidence-publications) - [Paediatric solid tumours](https://simsendiagnostics.com/evidence-paediatric-solid-tumours) - [CNS tumours & CSF ctDNA](https://simsendiagnostics.com/evidence-cns-csf-ctdna) - [White papers](https://simsendiagnostics.com/evidence-white-paper-ctdna-trials) - [COMPANY](https://simsendiagnostics.com/company-about) - [About us](https://simsendiagnostics.com/company-about) - [Team](https://simsendiagnostics.com/company-team) - [Contact us](https://simsendiagnostics.com/company-contact) - [News](https://simsendiagnostics.com/news) - [RESOURCES](https://simsendiagnostics.com/resources-hub) - [Sample collection guides](https://simsendiagnostics.com/resources-sample-collection-guides) - [Baseline kit guide](https://simsendiagnostics.com/baseline-collection-kit) - [Follow-up kit guide](https://simsendiagnostics.com/resources-followup-collection-kit) [For clinical trials Pharma and CROs Validate MRD endpoints, cut trial-arm cost, build EU regulatory readiness. Design a trial assay →](https://simsendiagnostics.com/solutions-trials) [For research and labs Translational oncology See signal in paediatric and early-stage samples your current platform misses. Send samples or run SiMSen-Seq in-house. See the signal →](https://simsendiagnostics.com/solutions-research) [For clinics Premium oncology monitoring Detect minimal residual disease ahead of imaging. Logistics across the EU, UK and EEA. Detect relapse earlier →](https://simsendiagnostics.com/solutions-clinic) [Home](https://simsendiagnostics.com/) / [Company](https://simsendiagnostics.com/company-about) / [News](https://simsendiagnostics.com/news) / Simsen Diagnostics to Present at GoCo Investor Day, Autumn 2025 [← Back to all news](https://simsendiagnostics.com/news) Corporate # Simsen Diagnostics to Present at GoCo Investor Day, Autumn 2025 By **Simsen** July 9, 2025, 3:42:26 PM GMT+02:00 1 min read ![](https://simsendiagnostics.com/hubfs/News-background.png) Simsen Diagnostics is excited to announce our participation in the upcoming **GoCo Investor Day**, a leading gathering for innovation, investment, and collaboration in life sciences. Taking place on **September 9, 2025** at **GoCo House** in Mölndal, Sweden, GoCo Investor Day brings together, for the second time, pioneering companies, investors, and ecosystem partners from across the sector. With a dynamic agenda featuring presentations from innovative life science businesses, the event is designed to accelerate connections and shape the future of health innovation. **At GoCo Investor Day, Simsen Diagnostics will:** - Present our latest advances in next-generation ctDNA solutions - Highlight our mission to transform cancer diagnostics and patient outcomes - Engage with investors, partners, and industry leaders to explore new collaborations We are scheduled to present from **11:30 to 11:45 AM**, offering insights into our technology and vision for the future. GoCo Investor Day is an outstanding opportunity to connect with key stakeholders, discover emerging trends, and be part of Sweden’s thriving life science ecosystem. **For more information or to register for the event, please visit:** [GoCo Investor Day 2025](https://sv-se.eu.invajo.com/event/gocohealthinnovationcitybioventurehub/gocoinvestordayseptember9) #### Share [mailto:?subject=Simsen+Diagnostics+to+Present+at+GoCo+Investor+Day%2C+Autumn+2025&body=https%3A%2F%2Fsimsendiagnostics.com%2Fnews%2Fgoco-investor-day-autumn-2025](mailto:?subject=Simsen+Diagnostics+to+Present+at+GoCo+Investor+Day%2C+Autumn+2025&body=https%3A%2F%2Fsimsendiagnostics.com%2Fnews%2Fgoco-investor-day-autumn-2025) #### On this page ## More from Simsen ### [June 16, 2026, 3:23:28 PM GMT+02:00 · Corporate Closing the gap between cancer research and patients is partly a question of where the test runs](https://simsendiagnostics.com/news/momentum2026-pre-event) ### [December 17, 2025, 11:57:23 AM GMT+01:00 · Corporate From more treatment to smarter treatment: how tumour‑informed ctDNA monitoring can reduce harm and free capacity in cancer care](https://simsendiagnostics.com/news/from-more-treatment-to-smarter-treatment-how-tumour-informed-ctdna-monitoring-can-reduce-harm-and-free-capacity-in-nordic-cancer-care) ### [November 17, 2025, 3:30:46 PM GMT+01:00 · Corporate Simsen Diagnostics Partners with One-carbon Therapeutics for Groundbreaking ODIN Cancer Trial](https://simsendiagnostics.com/news/simsen-diagnostics-partners-with-one-carbon-pharmaceuticals-for-groundbreaking-odin-cancer-trial) ### [November 11, 2025, 12:03:55 PM GMT+01:00 · Corporate How Pharma Companies Can Leverage Simsen Diagnostic’s Tumour-Informed ctDNA Analysis to Transform Cancer Drug Trials](https://simsendiagnostics.com/news/how-pharma-companies-can-leverage-simsen-diagnostics-tumour-informed-ctdna-analysis-to-transform-cancer-drug-trials) Talk to us ## Running a trial or service that needs this kind of signal? Tell us about your study and your endpoints. A real scientist in CET/CEST will reply. [Request a conversation](https://simsendiagnostics.com/start-a-conversation) [Back to all news](https://simsendiagnostics.com/news) ![full_lockup_white_CMYK kopia](https://simsendiagnostics.com/hs-fs/hubfs/full_lockup_white_CMYK%20kopia.png?width=166&height=45&name=full_lockup_white_CMYK%20kopia.png) **Visiting and postal address:** Pepparedsleden 1 431 53 Mölndal, Sweden **Shipping address:** c/o AstraZeneca R&D Mölndal Pepparedsleden 3 431 53 Mölndal, Sweden PLATFORM PLATFORM - [Platform overview](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) SOLUTIONS SOLUTIONS - [For clinical trials](https://simsendiagnostics.com/solutions-trials) - [For research and labs](https://simsendiagnostics.com/solutions-research) - [For clinics](https://simsendiagnostics.com/solutions-clinic) - [Solutions overview](https://simsendiagnostics.com/solutions-overview) COMPANY COMPANY - [About](https://simsendiagnostics.com/company-about) - [News](https://simsendiagnostics.com/news) - [Team](https://simsendiagnostics.com/company-team) - [Contact](https://simsendiagnostics.com/company-contact) - [Privacy policy](https://simsendiagnostics.com/legal-privacy-policy) - [Cookie Policy](https://simsendiagnostics.com/legal-cookie-policy) - [Terms of use](https://simsendiagnostics.com/legal-terms-of-use) © 2026 Simsen Diagnostics AB, All rights reserved. [Linkedin](https://www.linkedin.com/company/simsendiagnostics) Return to top ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Simsen", "url" : "https://simsendiagnostics.com/news/author/simsen" }, "dateModified" : "2025-07-09T13:42:26.445Z", "datePublished" : "2025-07-09T13:42:26.000Z", "headline" : "Simsen Diagnostics to Present at GoCo Investor Day, Autumn 2025", "image" : [ "https://simsendiagnostics.com/hubfs/News-background.png" ], "mainEntityOfPage" : { "@id" : "https://simsendiagnostics.com/news/goco-investor-day-autumn-2025", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://simsendiagnostics.com/hubfs/SD_logo%20medium-2.png" }, "name" : "Simsen Diagnostics AB" } } ```